Loading…

Formulation and Evaluation of a Transferosomal Gel of Famciclovir for Transdermal Use

Famciclovir, the drug of choice for cold sores and recurrent genital herpes, has poor oral bioavailability and is associated with numerous side effects. The study aimed to explore the possibility of transdermal application of famciclovir through a transferosome-loaded gelling system to localize the...

Full description

Saved in:
Bibliographic Details
Published in:Turkish journal of pharmaceutical sciences 2024-09, Vol.21 (4), p.303-312
Main Authors: Bhattacharyya, Sayani, Lakshmanan, Kalai Tamilselvi, Muthukumar, Andhuvan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c294t-d23ac5faaee53de3aba695eb212bb26cac267e802b6653ed98f3848b786bb9b83
container_end_page 312
container_issue 4
container_start_page 303
container_title Turkish journal of pharmaceutical sciences
container_volume 21
creator Bhattacharyya, Sayani
Lakshmanan, Kalai Tamilselvi
Muthukumar, Andhuvan
description Famciclovir, the drug of choice for cold sores and recurrent genital herpes, has poor oral bioavailability and is associated with numerous side effects. The study aimed to explore the possibility of transdermal application of famciclovir through a transferosome-loaded gelling system to localize the drug at the site of application with improved penetrability, therapeutic effects, and comfort. Transferosomes of famciclovir were prepared using tween 80, phospholipid, and cholesterol. To optimize drug entrapment and the vesicular size of the transferosomes, a central composite design was employed. The optimized formulation was evaluated for physicochemical characteristics, surface morphology, and degree of deformability. The optimized product was included in the Carbopol 940 gelling system. The gel was evaluated for ex vivo permeation, skin irritation, drug deposition at various skin layers, and histopathological analysis. The design optimization yielded an optimized product (FAMOPT) of nanosized (339 nm) stable vesicles of the transferosome of famciclovir. The surface morphology analysis revealed the formation of nanovesicles without aggregation. Compatibility between the drug and excipients was established. The elasticity of the vesicles demonstrated resistance to leakage. The permeation of the drug was enhanced by 2.8 times. The gel was found to be non-irritating and non-sensitizing to the animal skin. The drug deposition at various skin layers was remarkably improved, indicating effective drug penetration. The histopathological examination further demonstrated the penetration of nano-vesiculate drugs through deeper layers of the skin. Hence, nano-vesicular famciclovir delivery is a promising alternative to conventional famciclovir delivery with enhanced local and systemic action for herpes treatment.
doi_str_mv 10.4274/tjps.galenos.2023.46735
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11589086</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3100273145</sourcerecordid><originalsourceid>FETCH-LOGICAL-c294t-d23ac5faaee53de3aba695eb212bb26cac267e802b6653ed98f3848b786bb9b83</originalsourceid><addsrcrecordid>eNpVkU1LxDAQhoMouqh_QXv00jVfTdOTiPgFghcFb2GSTrWSNmvSLvjvbd1V9DTMzDvvDPMQcsroUvJSng_vq7R8BY99SEtOuVhKVYpihyw4kzpXXJa7ZMEElXkh6MsBOU7pnVLKKiFKLffJgag4l1TzBXm-CbEbPQxt6DPo6-x6DX7cpKHJIHuK0KcGY0ihA5_dop_rN9C51vmwbmPWhLhR1RhnyXPCI7LXgE94vI2H057rp6u7_OHx9v7q8iF3vJJDXnMBrmgAEAtRowALqirQcsat5cqB46pETblVqhBYV7oRWmpbamVtZbU4JBcb39VoO6wd9kMEb1ax7SB-mgCt-d_p2zfzGtaGsUJXVKvJ4WzrEMPHiGkwXZsceg89hjEZwSjlpWCymKTlRuqmZ6SIze8eRs0MxsxgzBaMmcGYbzDT5MnfM3_nfjCIL00sj-Y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3100273145</pqid></control><display><type>article</type><title>Formulation and Evaluation of a Transferosomal Gel of Famciclovir for Transdermal Use</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Bhattacharyya, Sayani ; Lakshmanan, Kalai Tamilselvi ; Muthukumar, Andhuvan</creator><creatorcontrib>Bhattacharyya, Sayani ; Lakshmanan, Kalai Tamilselvi ; Muthukumar, Andhuvan</creatorcontrib><description>Famciclovir, the drug of choice for cold sores and recurrent genital herpes, has poor oral bioavailability and is associated with numerous side effects. The study aimed to explore the possibility of transdermal application of famciclovir through a transferosome-loaded gelling system to localize the drug at the site of application with improved penetrability, therapeutic effects, and comfort. Transferosomes of famciclovir were prepared using tween 80, phospholipid, and cholesterol. To optimize drug entrapment and the vesicular size of the transferosomes, a central composite design was employed. The optimized formulation was evaluated for physicochemical characteristics, surface morphology, and degree of deformability. The optimized product was included in the Carbopol 940 gelling system. The gel was evaluated for ex vivo permeation, skin irritation, drug deposition at various skin layers, and histopathological analysis. The design optimization yielded an optimized product (FAMOPT) of nanosized (339 nm) stable vesicles of the transferosome of famciclovir. The surface morphology analysis revealed the formation of nanovesicles without aggregation. Compatibility between the drug and excipients was established. The elasticity of the vesicles demonstrated resistance to leakage. The permeation of the drug was enhanced by 2.8 times. The gel was found to be non-irritating and non-sensitizing to the animal skin. The drug deposition at various skin layers was remarkably improved, indicating effective drug penetration. The histopathological examination further demonstrated the penetration of nano-vesiculate drugs through deeper layers of the skin. Hence, nano-vesicular famciclovir delivery is a promising alternative to conventional famciclovir delivery with enhanced local and systemic action for herpes treatment.</description><identifier>ISSN: 1304-530X</identifier><identifier>ISSN: 2148-6247</identifier><identifier>EISSN: 2148-6247</identifier><identifier>DOI: 10.4274/tjps.galenos.2023.46735</identifier><identifier>PMID: 39224082</identifier><language>eng</language><publisher>Turkey: Galenos Publishing</publisher><subject>Original</subject><ispartof>Turkish journal of pharmaceutical sciences, 2024-09, Vol.21 (4), p.303-312</ispartof><rights>Copyright© 2024 The Author. Published by Galenos Publishing House on behalf of Turkish Pharmacists’ Association.</rights><rights>Copyright© The Author. Published by Galenos Publishing House on behalf of Turkish Pharmacists’ Association. 2024 Turkish Journal of Pharmaceutical Sciences</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c294t-d23ac5faaee53de3aba695eb212bb26cac267e802b6653ed98f3848b786bb9b83</cites><orcidid>0009-0008-3001-0863 ; 0000-0002-4013-4316 ; 0000-0002-4163-366X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11589086/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11589086/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,883,27907,27908,36996,53774,53776</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39224082$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bhattacharyya, Sayani</creatorcontrib><creatorcontrib>Lakshmanan, Kalai Tamilselvi</creatorcontrib><creatorcontrib>Muthukumar, Andhuvan</creatorcontrib><title>Formulation and Evaluation of a Transferosomal Gel of Famciclovir for Transdermal Use</title><title>Turkish journal of pharmaceutical sciences</title><addtitle>Turk J Pharm Sci</addtitle><description>Famciclovir, the drug of choice for cold sores and recurrent genital herpes, has poor oral bioavailability and is associated with numerous side effects. The study aimed to explore the possibility of transdermal application of famciclovir through a transferosome-loaded gelling system to localize the drug at the site of application with improved penetrability, therapeutic effects, and comfort. Transferosomes of famciclovir were prepared using tween 80, phospholipid, and cholesterol. To optimize drug entrapment and the vesicular size of the transferosomes, a central composite design was employed. The optimized formulation was evaluated for physicochemical characteristics, surface morphology, and degree of deformability. The optimized product was included in the Carbopol 940 gelling system. The gel was evaluated for ex vivo permeation, skin irritation, drug deposition at various skin layers, and histopathological analysis. The design optimization yielded an optimized product (FAMOPT) of nanosized (339 nm) stable vesicles of the transferosome of famciclovir. The surface morphology analysis revealed the formation of nanovesicles without aggregation. Compatibility between the drug and excipients was established. The elasticity of the vesicles demonstrated resistance to leakage. The permeation of the drug was enhanced by 2.8 times. The gel was found to be non-irritating and non-sensitizing to the animal skin. The drug deposition at various skin layers was remarkably improved, indicating effective drug penetration. The histopathological examination further demonstrated the penetration of nano-vesiculate drugs through deeper layers of the skin. Hence, nano-vesicular famciclovir delivery is a promising alternative to conventional famciclovir delivery with enhanced local and systemic action for herpes treatment.</description><subject>Original</subject><issn>1304-530X</issn><issn>2148-6247</issn><issn>2148-6247</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpVkU1LxDAQhoMouqh_QXv00jVfTdOTiPgFghcFb2GSTrWSNmvSLvjvbd1V9DTMzDvvDPMQcsroUvJSng_vq7R8BY99SEtOuVhKVYpihyw4kzpXXJa7ZMEElXkh6MsBOU7pnVLKKiFKLffJgag4l1TzBXm-CbEbPQxt6DPo6-x6DX7cpKHJIHuK0KcGY0ihA5_dop_rN9C51vmwbmPWhLhR1RhnyXPCI7LXgE94vI2H057rp6u7_OHx9v7q8iF3vJJDXnMBrmgAEAtRowALqirQcsat5cqB46pETblVqhBYV7oRWmpbamVtZbU4JBcb39VoO6wd9kMEb1ax7SB-mgCt-d_p2zfzGtaGsUJXVKvJ4WzrEMPHiGkwXZsceg89hjEZwSjlpWCymKTlRuqmZ6SIze8eRs0MxsxgzBaMmcGYbzDT5MnfM3_nfjCIL00sj-Y</recordid><startdate>20240902</startdate><enddate>20240902</enddate><creator>Bhattacharyya, Sayani</creator><creator>Lakshmanan, Kalai Tamilselvi</creator><creator>Muthukumar, Andhuvan</creator><general>Galenos Publishing</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0009-0008-3001-0863</orcidid><orcidid>https://orcid.org/0000-0002-4013-4316</orcidid><orcidid>https://orcid.org/0000-0002-4163-366X</orcidid></search><sort><creationdate>20240902</creationdate><title>Formulation and Evaluation of a Transferosomal Gel of Famciclovir for Transdermal Use</title><author>Bhattacharyya, Sayani ; Lakshmanan, Kalai Tamilselvi ; Muthukumar, Andhuvan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c294t-d23ac5faaee53de3aba695eb212bb26cac267e802b6653ed98f3848b786bb9b83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bhattacharyya, Sayani</creatorcontrib><creatorcontrib>Lakshmanan, Kalai Tamilselvi</creatorcontrib><creatorcontrib>Muthukumar, Andhuvan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Turkish journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhattacharyya, Sayani</au><au>Lakshmanan, Kalai Tamilselvi</au><au>Muthukumar, Andhuvan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Formulation and Evaluation of a Transferosomal Gel of Famciclovir for Transdermal Use</atitle><jtitle>Turkish journal of pharmaceutical sciences</jtitle><addtitle>Turk J Pharm Sci</addtitle><date>2024-09-02</date><risdate>2024</risdate><volume>21</volume><issue>4</issue><spage>303</spage><epage>312</epage><pages>303-312</pages><issn>1304-530X</issn><issn>2148-6247</issn><eissn>2148-6247</eissn><abstract>Famciclovir, the drug of choice for cold sores and recurrent genital herpes, has poor oral bioavailability and is associated with numerous side effects. The study aimed to explore the possibility of transdermal application of famciclovir through a transferosome-loaded gelling system to localize the drug at the site of application with improved penetrability, therapeutic effects, and comfort. Transferosomes of famciclovir were prepared using tween 80, phospholipid, and cholesterol. To optimize drug entrapment and the vesicular size of the transferosomes, a central composite design was employed. The optimized formulation was evaluated for physicochemical characteristics, surface morphology, and degree of deformability. The optimized product was included in the Carbopol 940 gelling system. The gel was evaluated for ex vivo permeation, skin irritation, drug deposition at various skin layers, and histopathological analysis. The design optimization yielded an optimized product (FAMOPT) of nanosized (339 nm) stable vesicles of the transferosome of famciclovir. The surface morphology analysis revealed the formation of nanovesicles without aggregation. Compatibility between the drug and excipients was established. The elasticity of the vesicles demonstrated resistance to leakage. The permeation of the drug was enhanced by 2.8 times. The gel was found to be non-irritating and non-sensitizing to the animal skin. The drug deposition at various skin layers was remarkably improved, indicating effective drug penetration. The histopathological examination further demonstrated the penetration of nano-vesiculate drugs through deeper layers of the skin. Hence, nano-vesicular famciclovir delivery is a promising alternative to conventional famciclovir delivery with enhanced local and systemic action for herpes treatment.</abstract><cop>Turkey</cop><pub>Galenos Publishing</pub><pmid>39224082</pmid><doi>10.4274/tjps.galenos.2023.46735</doi><tpages>10</tpages><orcidid>https://orcid.org/0009-0008-3001-0863</orcidid><orcidid>https://orcid.org/0000-0002-4013-4316</orcidid><orcidid>https://orcid.org/0000-0002-4163-366X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1304-530X
ispartof Turkish journal of pharmaceutical sciences, 2024-09, Vol.21 (4), p.303-312
issn 1304-530X
2148-6247
2148-6247
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11589086
source Publicly Available Content Database; PubMed Central
subjects Original
title Formulation and Evaluation of a Transferosomal Gel of Famciclovir for Transdermal Use
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T21%3A26%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Formulation%20and%20Evaluation%20of%20a%20Transferosomal%20Gel%20of%20Famciclovir%20for%20Transdermal%20Use&rft.jtitle=Turkish%20journal%20of%20pharmaceutical%20sciences&rft.au=Bhattacharyya,%20Sayani&rft.date=2024-09-02&rft.volume=21&rft.issue=4&rft.spage=303&rft.epage=312&rft.pages=303-312&rft.issn=1304-530X&rft.eissn=2148-6247&rft_id=info:doi/10.4274/tjps.galenos.2023.46735&rft_dat=%3Cproquest_pubme%3E3100273145%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c294t-d23ac5faaee53de3aba695eb212bb26cac267e802b6653ed98f3848b786bb9b83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3100273145&rft_id=info:pmid/39224082&rfr_iscdi=true